스냅차트

A Big Bounceback for Healthcare Private Equity

The industry logged records for the number of deals and disclosed value in 2021, and competition for deals should intensify.

스냅차트

A Big Bounceback for Healthcare Private Equity
en

In the second year of Covid-19, healthcare private equity activity showed remarkable resilience to the widespread disruption, posting a record year for both deal volume and disclosed value. This stemmed partly from a pandemic-induced backlog of parked deals, as well as the revival of megadeals. Competition looks set to intensify, following the record number of healthcare-focused funds initiated in 2021 and total capital raised. Major trends include these:

  • the consumerization of care;
  • digital solutions that improve operational efficiency;
  • a willingness to take on drug development risk;
  • large transactions in European biopharma and life sciences tools; and
  • an even higher baseline for deals in Asia-Pacific.

     

Read the Related Report

Healthcare Private Equity Market 2021: The Year in Review

The industry roared back after a pandemic-induced lull in 2020.

태그
태그

베인에 궁금하신 점이 있으신가요?

베인은 주저 없이 변화를 마주할 줄 아는 용감한 리더들과 함께합니다. 그리고, 이들의 담대한 용기는 고객사의 성공으로 이어집니다.